Replies to post #475688 on NorthWest Biotherapeutics Inc (NWBO)

[GermanCol]

As follows:

- The nGBM arm has 4.7% ( 11 / 232 ) MGMT unidentified
- The rGBM arm has 4.7% ( 3 / 64 ) MGMT unidentified
- The small group of non crossover has 63% ( 22 / 35 ) MGMT unidentified

So the total unidentified is 36 ( 11+3+22 ), corresponding to 11% ( 36 / 331) of the ITT population.

Information comes from the following tables:

FINAL RESULTS NEWLY DIAGNOSED GBM PATIENTS



FINAL RESULTS RECURRENT GBM PATIENTS



FINAL RESULTS - NON CROSSOVER PATIENTS



More details on the calcualtions are on the origial post:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168899638